High-achieving pharmaceutical sales professional with 4 years of experience in a wide range of medical specialties.
Outstanding record of exceeding sales targets in product portfolio market share and volume growth. Strong
commitment to a high level of therapeutic area knowledge and customer service. Multilingual (Fluent in Filipino,
conversational in Spanish). Advanced PC skills in Microsoft Word, Excel, and PowerPoint.
Sales Representative, SmithKline Beecham
(March 2007-February 2009)
Exceeded 100% of sales target
for product portfolio during 1st through 3rd quarters of 2008.
Ranked 7 out of 30
within the SmithKline Beecham sales force in the New York City region as of the 3rd
quarter of 2008.
Attained 259.9% total portfolio achievement
during the 3rd quarter of 2008.
Achieved 439.3% of sales target
for Lovaza in the 3rd quarter of 2008.
Generated over a 20% increase in market volume
and 10-point increase in market share
for Lovaza since
GSK launch in January 2008.
Exceeded at least 100% of sales target
for Avandia during 1st and 3rd quarters of 2008.
Won the “Avandia Turn the Corner” Contest in the 3rd quarter of 2008.
Awarded the “Diamond Kru District Award” for Coreg CR HIP/Emblemhealth prescriber expansion.
Awarded 100% Club
Recognition during new representative training.
Product portfolio included Coreg CR, Lovaza, and Avandia. Customer base included healthcare professionals in Cardiology, Endocrinology, and Primary Care. Sold product portfolio in Jamaica Hospital and Mary
Immaculate Hospital and corresponding outpatient clinics. Trained colleagues on hospital clinic selling.
Facilitated formulary review process for Lovaza within Caritas Healthcare System. Coordinated a territory selling team initiative to educate colleagues on relevant managed care prescription drug plans and to utilize
this knowledge to sell around any managed care barriers for the product portfolio.
JOHNSON & JOHNSON-ORTHO MCNEIL, Flushing, NY
Sales Representative, Women's Health & Urology
Achieved sales rank 1 of 90
in the Northeast Region during the 3rd quarter of 2006.
Awarded Long Island District Representative of the Quarter
in December 2006.
Ranked consistently in the top 10
in the Northeast region for Ortho Tri-Cyclen Lo market share change in
Maintained one of the top 5 market shares
for Ortho Tri-Cyclen Lo and Ortho Evra in the Northeast Region.
Expanded Elmiron market, resulting in 60% market volume growth throughout tenure.
Product portfolio included Ortho Tri-Cyclen Lo, Ortho Evra, Ditropan XL, and Elmiron. Customer base
included healthcare professionals in Obstetrics & Gynecology and Urology. Supported OBGYN residency
programs at Flushing Hospital and St. John's Queens Hospital through account management and product and
disease education. Sold product portfolio in Flushing Hospital, St. John's Queens Hospital, and Elmhurst
Hospital outpatient clinics. Served as customer relationship management software point person for the Long
MORGAN STANLEY, New York, NYBusiness Analyst, Retail Fixed Income, Futures, and Options
Managed a department-wide project to design and implement a trade balancing and reconciliation software
system that reduced fixed income trade records reconciliation time by 96%.
Assisted financial advisors in the general support and account management of futures and options trades.
Designed and engineered automated procedures to increase efficiency and accuracy in trade support.
FOREX CAPITAL MARKETS/ REFCOFX, New York, NY
Brought in over 286 client accounts and established an additional 217 leads.
Solely responsible for bringing in more than $4 million in assets
to the firm.
Provided sales and technical support services for clients of global forex broker. Specialized in selling and
supporting premium trading and technical analysis software to high net worth clientele.
Bachelor of Science, Information Systems and International Business, 2003
New York University – Stern School of Business, New York, NY
Con formato: Fuente: Cursiva El Genoma del Cáncer de Mama Alfredo Hidalgo Miranda1, Gerardo Jiménez Sánchez1, Sergio Rodríguez Cuevas2, Sandra Romero Córdoba1, Rosa Rebollar Vega1, Laura Uribe Figueroa1 1: Instituto Nacional de Medicina Genómica, México 2: Fundación Mexicana de Fomento Educativo para la Prevención y Detección Oportuna del Cáncer de Mama, A. C. (FUCAM) Ins
No será la Tierra de Jorge Volpi Por Alejandra Costamagna Hace poco más de un año Jorge Volpi fue invitado a un congreso de literatura en Corea, junto a una veintena de escritores de distintas nacionalidades. Un par de semanas después del encuentro, Volpi escribió una columna de opinión. Y se aplicó entonces en la tarea de definir a los asistentes al congreso de acuerdo con lo